Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
Wattel E, Guerci A, Hecquet B, Economopoulos T, Copplestone A, Mahé B, Couteaux ME, Resegotti L, Voglova V, Foussard C, Pegourié B, Michaux JL, Deconinck E, Stoppa AM, Mufti G, Oscier D, Fenaux P. Wattel E, et al. Among authors: resegotti l. Blood. 1996 Oct 1;88(7):2480-7. Blood. 1996. PMID: 8839839 Free article. Clinical Trial.
Hairy cell leukemia: splenectomy after alpha-interferon therapy.
Damasio EE, Resegotti L, Capnist G, Federico M, Foá R, Francia P, Lamparelli T. Damasio EE, et al. Among authors: resegotti l. Blood. 1992 Mar 1;79(5):1381. Blood. 1992. PMID: 1599545 Free article. No abstract available.
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA. Keating S, et al. Among authors: resegotti l. Bone Marrow Transplant. 1996 Jun;17(6):993-1001. Bone Marrow Transplant. 1996. PMID: 8807105 Clinical Trial.
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).
Bertini M, Freilone R, Botto B, Calvi R, Gallamini A, Gatti AM, Liberati AM, Meneghini V, Orlandi E, Orsucci L, Pizzuti M, Rota Scalabrini D, Salvi F, Todeschini G, Vitolo U, Resegotti L. Bertini M, et al. Among authors: resegotti l. Haematologica. 1997 May-Jun;82(3):309-13. Haematologica. 1997. PMID: 9234577 Clinical Trial.
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial.
Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F, Stryckmans P, Peetermans M, Thaler J, Resegotti L, Dardenne M, Willemze R. Zittoun R, et al. Among authors: resegotti l. Bone Marrow Transplant. 1997 Aug;20(4):307-15. doi: 10.1038/sj.bmt.1700888. Bone Marrow Transplant. 1997. PMID: 9285546
Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, et al. Zittoun RA, et al. Among authors: resegotti l. N Engl J Med. 1995 Jan 26;332(4):217-23. doi: 10.1056/NEJM199501263320403. N Engl J Med. 1995. PMID: 7808487 Free article. Clinical Trial.
157 results